A recent study has shown that intrauterine exposure to methylphenidate, commonly used in treating ADHD, increases the risk of heart defects in babies. The risk associated with the use of amphetamine is substantially lower. Given the rise in use of stimulants in pregnant women or young women of the reproductive age, the study can be of significant importance to doctors. During recent times, there has been a steady increase in the use of stimulants in pregnant women or in women of the reproductive age.
The use of methylphenidate and amphetamine is common in treating patients with attention deficit hyperactivity disorder (ADHD). However, according to a recent study published in JAMA Psychiatry, the use of methylphenidate during pregnancy substantially increases the risk of heart deformities or heart defect in babies. The study The cohort study, that was conducted in USA and Nordic…
